Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Sample-to-Answer Serum Diagnostics System-on-Chip.

Created on 17 Sep 2026

Authors

Zijun Zhao, Lu Wan, Kemin Wang, Jiajun Tong, Zhengwu Cao, Guojun Zhang, Xiaofeng Liu, Yiwei Liu, Zhiyong Zhang

Published in

ACS sensors. Sep 16, 2026. Epub Sep 16, 2026.

Abstract

Integrating multiple bioanalytical functions onto a single chip for point-of-care protein detection remains challenging. Here, we introduce a biological detection system-on-chip (BDSoC) that merges the purification capabilities of microfluidic chips with the detection sensitivity of carbon nanotube (CNT) field-effect transistor (FET) biosensors, achieving ultrasensitive analysis of trace protein biomarkers in complex samples. The BDSoC device allows direct and precise detection of tumor biomarkers in undiluted serum across an exceptionally low concentration range from 2 fg/mL to 1 pg/mL and correctly classified all 24 clinical serum samples tested in this study, corresponding to an observed diagnostic accuracy of 100% in this preliminary cohort. The platform is highly scalable, allowing for the future integration of biosensor arrays for multiplexing, advanced fluidic control, and versatile sample processing modules. This work marks a significant advance toward the ultimate vision of the "single-drop blood test" SoC, accelerating the practical deployment of FET biosensors and their evolution in point-of-care diagnostic technologies.

PMID:
42748330
Bibliographic data and abstract were imported from PubMed on 17 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement